Finepoint Capital’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $13.9M | Hold |
|
|||||
|
2024
Q2 | $14.7M | Buy |
|
|||||
|
2024
Q1 | $15.5M | Buy |
|
|||||
|
2023
Q4 | $24.1M | Buy |
|
|||||
|
2023
Q3 | $11.6M | Sell |
|
|||||
|
2023
Q2 | $20.3M | Sell |
|
|||||
|
2023
Q1 | $17.2M | Sell |
|
|||||
|
2022
Q4 | $18.7M | Buy |
|
|||||
|
2022
Q3 | $18.2M | Buy |
|
|||||
|
2022
Q2 | $9.96M | Buy |
|